RESUMO
Diabetes mellitus (DM) is a chronic disease at all ages including childhood and puberty. Failure to treat DM can cause retinopathy, nephropathy and neuropathy. Endocrine and metabolic changes during the pubertal period complicate management of DM. Noopept is a cognitive enhancer that exhibits antidiabetic properties. We investigated the effect of noopept on the histopathology of the cornea, retina, kidney and pancreas in pubertal diabetic rats. We allocated 60 prepubertal male rats randomly into six groups of 10: untreated control (C), DM control (DC), noopept control (NC), DM + noopept (D + N), DM + insulin (D + I) and DM + insulin + noopept (D + I + N). DM was induced by streptozotocin in the DC, D + N, D + I and D + I + N groups. Noopept was administered to the NC, D + N and D + I + N groups; insulin was administered to the D + I and D + I + N groups for 14 days. On day 18 of the experiment, animals were sacrificed and eyes, kidneys and pancreata were excised for histological investigation. Renal tubule diameter and corneal and retinal thickness were increased significantly in DC groups compared to the control group. The D + I, D + N and D + I + N groups exhibited fewer DM induced pathological changes than the DC group. The D + I + N group exhibited no significant differences in renal tubule diameter and corneal and retinal thickness compared to the DC group. Our findings suggest that noopept is protective against DM end organ complications in streptozotocin induced diabetic pubertal rats.
Assuntos
Diabetes Mellitus Experimental , Ratos , Masculino , Animais , Diabetes Mellitus Experimental/metabolismo , Estreptozocina/farmacologia , Maturidade Sexual , Rim , Insulina/farmacologia , Insulina/metabolismo , PâncreasRESUMO
BACKGROUND: Oxidative stress and inflammation play a critical role in the etiopathogenesis of bronchopulmonary dysplasia (BPD). The aim of this study was to evaluate the preventive effect of Chrysin (CH), an antioxidant, antiinflammatory, antiapoptotic and antifibrotic drug, on hyperoxia-induced lung injury in a neonatal rat model. METHODS: Forty infant rats were divided into four groups labeled the Control, CH, BPD, and BPD + CH. The control and CH groups were kept in a normal room environment, while the BPD and BPD + CH groups were kept in a hyperoxic (90-95%) environment. At the end of the study, lung tissue was evaluated with respect to apoptosis, histopathological damage and alveolar macrophage score as well as oxidant capacity, antioxidant capacity, and inflammation. RESULTS: Compared to the BPD + CH and control groups, the lung tissues of the BPD group displayed substantially higher levels of MDA, TOS, TNF-α, and IL-1ß (p < 0.05). While the BPD + CH group showed similar levels of TNF-α and IL-1ß as the control group, MDA and TOS levels were higher than the control group, and significantly lower than the BPD group (p < 0.05). The BPD group exhibited considerably lower levels of TAS, SOD, GSH, and GSH-Px in comparison to the control group (p < 0.05). The BPD and BPD + CH groups exhibited higher mean scores of histopathological damage and alveolar macrophage when compared to the control and CH groups (p ≤ 0.0001). Both scores were found to be lower in the BPD + CH group in comparison to the BPD group (p ≤ 0.0001). The BPD + CH group demonstrated a significantly lower average of TUNEL and caspase-3 positive cells than the BPD group. CONCLUSION: We found that prophylaxis with CH results in lower histopathological damage score and reduces apoptotic cell count, inflammation and oxidative stress while increasing anti-oxidant capacity.
Assuntos
Antioxidantes/farmacologia , Flavonoides/farmacologia , Hiperóxia , Lesão Pulmonar/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Antioxidantes/uso terapêutico , Apoptose/efeitos dos fármacos , Displasia Broncopulmonar/etiologia , Displasia Broncopulmonar/metabolismo , Displasia Broncopulmonar/patologia , Displasia Broncopulmonar/prevenção & controle , Caspase 3/metabolismo , Modelos Animais de Doenças , Flavonoides/uso terapêutico , Glutationa Peroxidase/metabolismo , Glutationa Redutase/metabolismo , Hiperóxia/induzido quimicamente , Interleucina-1beta/metabolismo , Lesão Pulmonar/etiologia , Lesão Pulmonar/metabolismo , Lesão Pulmonar/patologia , Macrófagos Alveolares/metabolismo , Malondialdeído/metabolismo , Oxidantes/metabolismo , Oxigênio/efeitos adversos , Ratos Wistar , Superóxido Dismutase/metabolismo , Fator de Necrose Tumoral alfa/metabolismoRESUMO
AIM: Type 1 diabetes (T1DM) is a common chronic disease in childhood. Increasing insulin resistance in puberty gives rise to higher doses of insulin usage in treatment. Of this reason new approaches in treatment are needed. Noopept researches suggest it to have anti-diabetic properties. We tried to determine the effects of noopept on pubertal diabetes. MAIN METHOD: The research was made with 60 prepubertal, 28â¯day-old, male, Sprague Dawley rats. The rats were divided into randomised 6 groups (nâ¯=â¯10/group). i) Control, ii) Diabetes Control, iii) Noopept Control, iv) Diabetesâ¯+â¯Noopept, v) Diabetesâ¯+â¯Insulin, vi) Diabetesâ¯+â¯Insulinâ¯+â¯Noopept. T1DM model was induced by streptozotocin on postnatal 28th day. 0.5â¯mg/kg noopept and 1â¯IU insulin were administered intraperitoneally for 14â¯days. Blood glucose and body weight measurements, puberty follow-up and MWM tests were performed. Hippocampus, hypothalamus and testis were evaluated histologically. Hypothalamic GnRH and kisspeptin were studied immunohistochemically. Serum LH, FSH and insulin, hippocampal homogenate NGF and BDNF levels were determined by ELISA. KEY FINDINGS: Delayed puberty was normalized by noopept (pâ¯<â¯0.05). Blood glucose levels were lower in noopept-administered diabetic groups (pâ¯<â¯0.05). Noopept decreased HOMA-IR in insulin administered diabetic group (pâ¯<â¯0.05). Number of degenerated cells in hippocampus and testis were higher in diabetes control group when compared with other groups (pâ¯<â¯0.05). GnRH immunoreactivity in Diabetesâ¯+â¯Noopept group was increased when compared to insulinâ¯+â¯noopept group (pâ¯=â¯0.018). There was no difference in kisspeptin, serum LH, FSH, hippocampal NGF-BDNF levels and spatial learning assessment among groups (pâ¯>â¯0.05). SIGNIFICANCE: Noopept may have positive effect in treatment of pubertal diabetes.